Biolife Solutions (BLFS) Short-term Investments (2014 - 2026)

Biolife Solutions (BLFS) has 9 years of Short-term Investments data on file, last reported at $58.2 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $58.2 million, up 168.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.2 million (up 168.89% YoY), and the FY2025 annual result was $55.9 million, up 507.62% from the prior year.
• Short-term Investments grew to $58.2 million in Q1 2026 per BLFS's latest filing, from $55.9 million in the prior quarter.
• Over five years, Short-term Investments peaked at $58.2 million in Q1 2026 and troughed at $10000.0 in Q1 2022.
• A 5-year average of $21.8 million and a median of $16.3 million in 2023 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments slumped 99.91% in 2023, then soared 160751.61% in 2025.
• A 5-year view of Short-term Investments shows it stood at $43.3 million in 2022, then sank by 62.35% to $16.3 million in 2023, then slumped by 43.53% to $9.2 million in 2024, then soared by 507.62% to $55.9 million in 2025, then advanced by 4.09% to $58.2 million in 2026.
• Business Quant data shows BLFS's Short-term Investments at $58.2 million in Q1 2026, $55.9 million in Q4 2025, and $49.5 million in Q3 2025.